KindlyMD is now providing nearly 80% statewide comprehensive insurance coverage

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

FDA Provides Positive Feedback to Company Regarding TH104 Phase 2 Program

Company Incorporating FDA Feedback into Phase 2 Protocol

Company Believes it is On-track to Initiate Phase 2 Trial

Multiple new structures indicate material strike and depth potential

Platform established for 2024 Scoping Studies and high-grade targeting

~224koz added at only A$16/oz; Barton total JORC Resources now ~1.5Moz

~189koz added at cost of only A$12 / oz; Barton total MRE now 1.3Moz

Binding Agreement Follows 2022 Term Sheet & Phase 1 Analysis

Treasury Boosted by Mill Cleanup & Record AUD Gold Prices

The Sports, Entertainment & Innovation Conference "SEICon" Takes Place on July 15 - 17 in Las Vegas

GameSquare Will Feature Activations, Presentations and Panels from Industry Leaders in the Gaming, Esports, and Media Markets

Clinical trials for AI Nose-powered Ainos Flora device moves forward with 75 meaningful case results, paving the way for next-gen product targeting at-home testing

Next-Gen Ainos Flora will advance with NVIDIA CUDA, targeting Q3 for design completion and Q4 for clinical trial kickoff

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.